Nebulised RESP30X Nitric Oxide Formulations

· Thirty Respiratory Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nebulised RESP30X Nitric Oxide Formulations, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa) [Phase 1, Phase 2]